• 1
    Ball EJ, Khan MA. HLA–B27 polymorphism. Joint Bone Spine 2001; 68: 37882.
  • 2
    D'Amato M, Fiorillo MT, Carcassi A, Mathieu A, Zuccarelli A, Bitti PP, et al. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur J Immunol 1995; 25: 3199201.
  • 3
    Marchionni L, Modena V, Roggero R, Curtoni ES. The polymorphism of HLA-B27 and the seronegative spondyloarthropathies in the Italian population [abstract]. In: 13th European Histocompatibility Conference; Crete 1999. European Federation for Immunogenetics: 36.
  • 4
    Olivieri I, Padula A, Ciancio G, Moro L, Durante B, Gaudiano C, et al. The HLA-B*2709 subtype in a patient with undifferentiated spondarthritis [letter]. Ann Rheum Dis 2000; 59: 6545.
  • 5
    Nasution AR, Mardjuadi A, Kunmartini S, Suryadhana NG, Setyohadi B, Sudarsono D, et al. HLA-B27 subtypes positively and negatively associated with spondyloarthropathy. J Rheumatol 1997; 24: 11114.
  • 6
    Sudarsono D, Hadi S, Mardjuadi A, Nasution AR, Dekker-Sayes A, Breur-Vrisendorp BS, et al. Evidence that HLA-B*2706 is not protective against spondyloarthopathy. J Rheumatol 1999; 26: 19346.
  • 7
    Rendine S, Borelli I, Barbanti M, Sacchi M, Roggero R, Curtoni ES. HLA polymorphisms in Italian bone marrow donors: a regional analysis. Tissue Antigens 1998; 52: 13546.
  • 8
    Garcia-Peydro M, Marti M, Lopez de Castro JA. High T cell epitope sharing between two HLA-B27 subtypes (B*2505 and B*2709) differentially associated to ankylosing spondylitis. J Immunol 1999; 163: 2299305.
  • 9
    Guis-Sabatier S, Nielsen W, Boetsch G, Dutour O, Mercier P, Reviron D, et al. In Southern France, HLA-B*2702 carries susceptibility and HLA-B*2705 carries resistance to ankylosing spondylitis in patients of Spanish and North African descent [abstract]. Arthritis Rheum 2000; 43( Suppl): S266.